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Abstract
Coronary ectasia presenting as a recurrent inferior myocardial infarction 
has rarely been reported in the literature. Herein, we report a 61-year-old 
man who presented with persistent chest pain accompanied by ST segment 
elevation in the inferior ECG leads. Coronary angiography showed ectasia 
of the right coronary artery (RCA) and total occlusion from the middle RCA. 
Two stents were implanted separately in the middle and distal RCA. The 
patient was readmitted due to recurrent inferior wall infarction 15 months 
after discharge. He underwent primary percutaneous coronary intervention 
again, and coronary angiography showed massive thrombosis and in-stent 
re-stenosis. The thrombosis and re-stenosis were successfully treated using 
balloon angioplasty. The patient was discharged under medical therapy with 
aspirin and clopidogrel. There were no anginal symptoms during the 3 years 
of follow up. [Tzu Chi Med J 2010;22(2):119–122]
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1. Introduction
Coronary artery ectasia (CAE) is a coronary anomaly 
that results in significant dilatation of one or more of 
the major coronary arteries. The angiographic diagnos-
tic criteria of CAE is a segment of the artery with a 
diameter > 1.5 times the normal segment [1]. The 
prevalence of CAE is 0.3–12% at autopsies and during 
coronary angiography or multidetector computed to-
mography [2,3]. Recurrent acute myocardial infarction 
(AMI) in the presence of coronary ectasia is uncom-
mon, comprising < 1% of all cases of coronary ectasia. 
Therefore, we report a case of recurrent AMI in the 
presence of coronary ectasia from our institution.
2. Case report
A 61-year-old man was admitted to Dalin Tzu Chi 
General Hospital because of the sudden onset of se-
vere substernal chest pain with radiation to the left 
arm and jaw 2 hours prior to admission. The associated 
symptoms included nausea, vomiting, cold sweating, 
and dyspnea.
He had a history of angina that was relieved by 
nitroglycerin prior to this admission, but the pain had 
become progressively more frequent and was occur-
ring while at rest. He was diagnosed with hypertension 
10 years prior to this admission and had a history of 
hyperlipidemia. On physical examination, his blood 
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pressure was 140/94 mmHg. His lungs were clear and 
sinus rhythm was present. There were no murmurs, 
gallop sounds, or friction rubs. The pulses were equal 
in the upper and lower extremities.
The resting electrocardiogram showed ST segment 
elevation in leads II, III and AVF, and AMI was diag-
nosed. Emergent coronary catheterization was per-
formed and revealed total occlusion from the middle 
right coronary artery (RCA). The left main coronary ar-
tery, anterior descending and circumflex arteries were 
normal. Mild posterior and basal hypokinesis was 
noted on left ventriculography.
Primary percutaneous transluminal coronary angi-
oplasty (PTCA) of the total RCA occlusion was per-
formed using a 7-F guiding catheter and a 3.0-mm 
Maverick balloon dilation catheter over a 0.014-inch 
steerable wire. We chose a 3.0-mm balloon because 
the normal segment of the RCA (p-RCA) was 3.0 mm. 
Following PTCA, there was an intima flap from a longitu-
dinal plane of dissection without significant obstruction 
of flow. Coronary ectasia was noted because of the di-
lated middle and distal RCA (4.53 mm in maximal diam-
eter, but not the stenotic site). Two stents (bare metal 
stents, 3.5 × 20 mm) were implanted in the middle 
and distal RCA. The patient was asymptomatic and sta-
ble hemodynamically. Intravenous heparin was infused 
continuously for 24 hours, and he had an uneventful 
recovery. Atrioventricular block present at the time of 
admission had disappeared after several days (Figs. 1 
and 2). Dual antiplatelet therapy (aspirin and clopidog-
rel) was given for 3 months after stent implantation.
The patient remained asymptomatic for 15 months 
after discharge, but then he noted the return of chest 
pains. Repeat coronary angiography showed total oc-
clusion from the proximal RCA. The left coronary artery 
system remained normal. Primary PTCA was success-
fully performed; however, some thrombus remained 
Fig. 1 — Pre-catheterization.
Fig. 2 — Post-catheterization.
Fig. 3 — Pre-catheterization (15 months later).
Fig. 4 — Post-catheterization (15 months later).
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in the RCA (Figs. 3 and 4). Heparin was administered 
for 5 days. The patient performed well under medi-
cal treatment with clopidogrel, diltiazem, aspirin, and 
lovastatin. Dual antiplatelet therapy (aspirin and clopi-
dogrel) was given for 1 year. There were no further 
anginal symptoms during 3 years of follow-up.
3. Discussion
CAE has been observed by pathologists and cardiolo-
gists for more than two centuries. This coronary anom-
aly was first described by Morgagni in 1761 [4]. Bourgon 
was the first to describe the postmortem findings of 
RCA dilatation in a patient who experienced sudden 
death in 1812 [5]. The term “ectasia” was first used 
by Bjork in 1966 to describe dilated coronary arteries 
[6]. The proximal and middle parts of the RCA are most 
commonly affected by ectasia, although the reasons 
for this are not clear. Involvement of the left anterior 
descending artery and left circumflex artery is varia-
ble. The left main coronary artery is less commonly in-
volved. Most cases of CAE involve only a single vessel.
More than 50% of CAE cases were reportedly caused 
by atherosclerosis [7–9]. Compensatory vessel enlarge-
ment in the presence of coronary atherosclerotic 
plaques is a common phenomenon that is viewed as 
positive remodeling [10]. Progressive overcompensa-
tion leading to ectasia may be caused by an inadequate 
extent of media atrophy and fracture of the internal 
elastic lamina, as well as atypical rearrangement of 
smooth muscle cells [11,12]. Virmani et al [13] pro-
vided a detailed pathologic characterization of CAE, 
including lipid deposition with foam cells, fibrous 
caps, and significant loss of smooth muscle and 
elastic components of the vascular wall as the main 
histologic abnormalities. The reason for why stenosis 
develops in some individuals with atherosclerosis, and 
dilatation occurs in others is unknown.
In this report, we described a patient with CAE 
and recurrent thrombus resulting in AMI. While this 
patient had a history of diabetes mellitus, hyperlipi-
demia and hypertension, coronary angiography re-
vealed only mild atherosclerosis in the left coronary 
artery. However, significant diffuse ectasia was noted 
in the RCA which was accompanied by recurrent 
thrombosis and AMI. It is likely that the patient had 
recurrent myocardial infarction due to very late in-stent 
thrombosis and coronary ectasia. Reduced flow within 
the dilated segments has been demonstrated and 
might predispose a patient to thrombotic occlusions 
of the affected artery [14]. We discovered a massive 
thrombus in the proximal and middle RCA during the 
second intervention. However, coronary flow was still 
reduced after suction of the thrombosis. Coronary 
flow reached TIMI-3 until the fully dilated distal RCA 
in-stent re-stenosis was done.
CAE is not a benign coronary anomaly. Sorrel et al 
[15] suggested treating CAE patients with: (1) chronic 
warfarin therapy with the maintenance of an interna-
tional normalized ratio of 2.0–2.5 to reduce the risk 
of thrombosis; (2) aspirin (80–360 mg/day) to minimize 
platelet aggregation; and (3) calcium-channel block-
ers to prevent coronary vasospasm. Therapy should 
be tailored to each individual patient because of the 
serious bleeding complications associated with war-
farin use. Heparin and thrombolytic therapy have been 
successfully used for recanalization. For patients 
with co-existing obstructive lesions and refractory 
angina despite medical treatment, percutaneous cor-
onary intervention (PCI) can be performed. However, 
stents may be difficult to deploy because the ectatic 
arteries are usually much larger than normal arter-
ies. Selection of a stent of adequate size and its ex-
pansion are very important, and can be determined 
by intravascular ultrasound. Coronary artery bypass 
grafting (CABG) has been used for many years for the 
treatment of significant coronary artery disease co-
existing with CAE, and the postoperative outcome 
has been uniformly good. Valente et al [16] reported 
that the prognosis of CAE was good with a low mor-
tality rate (2%), possibly because their patients with 
ST-elevation AMI and acute coronary syndrome all 
underwent PCI, and the most severe cases with co-
existing coronary stenosis underwent CABG. Our pa-
tient received primary PCI twice with good results. 
However, continuous double antiplatelet therapy may 
be the main reason underlying the good prognosis 
and symptom-free survival for 3 years.
CAE is worthy of closer study. Treatment should 
be tailored according to clinical manifestations and 
the number and involvement of the coronary arter-
ies. Medical therapy is recommended for patients 
with symptomatic non-obstructive CAE. PCI may be 
performed in some patients, but the choice of stent 
size is a challenging issue. Surgery (CABG, aneurysm 
ligation or aneurysmectomy) is a better choice for 
patients who are refractory to medical therapy and 
not suitable for PCI.
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